FOR2240-Logo2FOR2240-Logo2FOR2240-Logo2FOR2240-Logo2
  • Home
  • About
  • Projects
    • P1 Lymph-Transplant
    • P2 Modulators of LA
    • N1 Ocular GvHD
    • N2 ABCB5 & Pterygium
    • P4 Ocular Melanoma
    • P5 Myeloid Cells
    • P6 Microglia in AMD
    • P8 Uveitis
    • C1 Eye Imaging
    • C2 Management
    • Publication highlights
  • Team
    • Executive Board
    • Research Groups
    • Central Projects
    • Associated projects
    • Alumni
  • Links
  • Events
    • Guest lectures
    • Retreats
    • Symposium
  • News
✕

Prof. Cursiefen new ARVO Fellow and incoming DOG President

Claus Cursiefen

Claus Cursiefen

Shortly before its April 2018 annual meeting in Honolulu, Hawaii, the Association for Research in Vision and Ophthalmology (ARVO) appointed Prof. Claus Cursiefen as a Fellow. Prof. Cursiefen is the Chair of the Department of Ophthalmology at the University Hospital of Cologne and the Speaker of the German Research Foundation Research Unit FOR 2240 “Angiogenesis, Lymphangiogenesis and Cellular Immunity in Inflammatory Diseases of the Eye”. This honor is extended to only 28 ophthalmologists worldwide, and to only three other Germans. The organization is the largest of its kind in the world, focusing on ophthalmologic research. The appointment as a Fellow honors Prof. Cursiefen’s scientific accomplishments and his commitment to supporting young researchers. ARVO Fellows have shown in their research endeavors that they are committed to the goals of the society on an international level, namely furthering the understanding of the visual system and the prevention, treatment and cure of eye diseases.
In addition, Prof. Cursiefen is set to become the new president of the German Ophthalmological Society (DOG). After the annual meeting of the DOG in October 2018 in Bonn, Prof. Cursiefen will become its president, and will assume responsibility for organizing the annual meeting 2019 in Berlin. Prof. Cursiefen notes that “The DOG, with over 7000 members, is THE scientific ophthalmology society in Germany, and is the oldest of its kind in the world.” Furthermore, “next to our goal of actively promoting ophthalmologic research, we also want to recruit motivated young researchers. Ophthalmology is a very successful field: we can help patients a lot, but we also have a lot of unsolved problems to be tackled by research. We need to get more young doctors excited about this dynamic and attractive specialty.”
[This news items is based on two German language articles: https://www.uk-koeln.de/uniklinik-koeln/aktuelles/detailansicht/prof-cursiefen-neuer-arvo-fellow/ and https://augenklinik.uk-koeln.de/informationen/aktuelles/detailansicht/prof-cursiefen-in-dog-vorstand-berufen/]

Related posts

January 7, 2023

Dr. Sarah Barbara Zwingelberg, is awarded Belmonte Fellowship for research on the neurobiology of the ocular surface


Read more
December 15, 2022

Leonhard Klein-Preis for Prof. Matthaei


Read more
November 22, 2022

4th Shanghai-Cologne Scientific Symposium


Read more

News

  • Rare eye diseases: Eight million euros for research: Funding for four years
  • Dr. Sarah Barbara Zwingelberg, is awarded Belmonte Fellowship for research on the neurobiology of the ocular surface
  • Experimental Glaucoma Research Group awarded and funded
  • Leonhard Klein-Preis for Prof. Matthaei
  • 4th Shanghai-Cologne Scientific Symposium

More information

  • Publication highlights
  • Jobs
  • Contact
  • Impressum
  • Datenschutz

Newest publications

Supplemental Anti Vegf A-Therapy Prevents Rebound…(2020)


Bevacizumab Induces Upregulation of Keratin 3 and VEGFA in Human…(2020)


Immune reactions after modern lamellar (DALK, DSAEK, DMEK) versus conventional…(2020)


Contact

Esther Engel
Management Office
DFG Research Unit FOR2240
Department of Ophthalmology
University of Cologne
Kerpener Str. 62
50937 Cologne, Germany

www.for2240.de

Tel. +49 (0)221 478 32845
Fax. +49 (0)221 478 5094
esther.engel@uk-koeln.de

Partnerlogos

© 2021 FOR2240 | Online Marketing von Resulted Lübeck